Severe cytopenia in dogs treated with fenbendazole for Heterobilharzia americana

Objective: To report the features and outcomes of dogs experiencing severe febrile cytopenia following treatment with fenbendazole for Heterobilharzia americana. Animals: 6 client-owned dogs that received fenbendazole for treatment of H americana and subsequently developed severe transient cytopenia with accompanying clinical illness were evaluated. Clinical Presentation: In this observational retrospective multicenter case series, medical records of affected dogs reported by veterinarians through consultation with the Gastrointestinal Laboratory at Texas A&M University between June 2023 and November 2025 were reviewed. Dogs were included if they had a diagnosis of H americana by fecal PCR or saline sedimentation, received treatment with fenbendazole, and developed an episode of cytopenia with accompanying clinical signs within 21 days of beginning treatment. Results: All dogs were spayed females, representing a variety of breeds. Six dogs received praziquantel and fenbendazole for treatment. Five of these dogs received concurrent doses of pyrantel pamoate and febantel through use of a combination tablet as the source of praziquantel, resulting in high total benzimidazole drug exposure. Dogs developed marked neutropenia, variable thrombocytopenia, fever, and severe clinical illness warranting hospitalization. All dogs experienced hematologic and clinical recovery following discontinuation of fenbendazole, supportive care, and administration of short-term parenteral antimicrobials. Clinical Relevance: Prescribing veterinarians should remain aware of the risk for cytopenia with extralabel use of fenbendazole to treat H americana infection in dogs. The use of combination products to dose praziquantel is contraindicated, as it may also contain febantel and could expose dogs to toxic doses of benzimidazole.

Authors

Institutions

Publication Details

Journal
Journal of the American Veterinary Medical Association
Published
2026-11-18
DOI
https://doi.org/10.2460/javma.26.08.0611
Primary Topic
Helminth infection and control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Severe cytopenia in dogs treated with fenbendazole for Heterobilharzia americana

Kathleen M. Aicher, Virginia R. Fajt, Guilherme G. Verocai, Lea Josefine Poellmann
1 links
Journal of the American Veterinary Medical Association
Helminth infection and control
article

Severe cytopenia in dogs treated with fenbendazole for Heterobilharzia americana

Kathleen M. Aicher, Virginia R. Fajt, Guilherme G. Verocai, Lea Josefine Poellmann
article en

Abstract

Objective: To report the features and outcomes of dogs experiencing severe febrile cytopenia following treatment with fenbendazole for Heterobilharzia americana. Animals: 6 client-owned dogs that received fenbendazole for treatment of H americana and subsequently developed severe transient cytopenia with accompanying clinical illness were evaluated. Clinical Presentation: In this observational retrospective multicenter case series, medical records of affected dogs reported by veterinarians through consultation with the Gastrointestinal Laboratory at Texas A&M University between June 2023 and November 2025 were reviewed. Dogs were included if they had a diagnosis of H americana by fecal PCR or saline sedimentation, received treatment with fenbendazole, and developed an episode of cytopenia with accompanying clinical signs within 21 days of beginning treatment. Results: All dogs were spayed females, representing a variety of breeds. Six dogs received praziquantel and fenbendazole for treatment. Five of these dogs received concurrent doses of pyrantel pamoate and febantel through use of a combination tablet as the source of praziquantel, resulting in high total benzimidazole drug exposure. Dogs developed marked neutropenia, variable thrombocytopenia, fever, and severe clinical illness warranting hospitalization. All dogs experienced hematologic and clinical recovery following discontinuation of fenbendazole, supportive care, and administration of short-term parenteral antimicrobials. Clinical Relevance: Prescribing veterinarians should remain aware of the risk for cytopenia with extralabel use of fenbendazole to treat H americana infection in dogs. The use of combination products to dose praziquantel is contraindicated, as it may also contain febantel and could expose dogs to toxic doses of benzimidazole.

Journal of the American Veterinary Medical Association
Texas A&M University (US)
Good health and well-being
Helminth infection and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon